Key Findings

Berberine was identified as a novel efflux inhibitor that attenuates MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa. It reduces the minimum inhibitory concentration (MIC) of aminoglycosides in multidrug-resistant strains and shows synergistic effects with antibiotics like amikacin and piperacillin.